Alpha-synuclein kinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8148089
APP PUB NO 20100143946A1
SERIAL NO

12702201

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 kinase.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELAN PHARMA INTERNATIONAL LIMITEDTREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, John P San Francisco, US 62 1651
Banducci, Kelly Pleasanton, US 4 10
Basi, Guriqbal S Palo Alto, US 13 62
Chereau, David San Mateo, US 4 10
Chilcote, Tamie J San Francisco, US 21 379
Frigon,, Jr Normand L Millbrae, US 3 4
Goldstein, Jason Burlingame, US 15 189
Griswold, Irene San Francisco, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation